Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.60
-0.0300-1.84%
Post-market: 1.600.00000.00%17:02 EDT
Volume:388.41K
Turnover:628.38K
Market Cap:115.42M
PE:-0.70
High:1.65
Open:1.63
Low:1.59
Close:1.63
52wk High:5.44
52wk Low:1.01
Shares:72.14M
Float Shares:49.98M
Volume Ratio:0.67
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2763
EPS(LYR):-2.3331
ROE:-49.55%
ROA:-25.41%
PB:0.42
PE(LYR):-0.69

Loading ...

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Sep 03

BRIEF-Zentalis Pharmaceuticals Appoints James B. Bucher, JD, As Chief Legal Officer And Corporate Secretary

Reuters
·
Aug 27

Zentalis Pharmaceuticals Appoints James B. Bucher, Jd, as Chief Legal Officer and Corporate Secretary

THOMSON REUTERS
·
Aug 27

Zentalis Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 07

Zentalis Pharma Q2 EPS $(0.37) Beats $(0.51) Estimate, $303.4M Cash, Cash Equivalents And Marketable Securities Supports Operational Runway Into Late 2027

Benzinga
·
Aug 07

Zentalis Pharma's Q2 operating expenses down

Reuters
·
Aug 07

Zentalis Pharmaceuticals Q2 Net Income USD -26.874 Million

THOMSON REUTERS
·
Aug 07

Zentalis Pharmaceuticals Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Aug 05

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Jul 02

Zentalis Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 19

Zentalis Pharmaceuticals Inc. to Present at Jefferies Healthcare Conference in New York

Reuters
·
May 20

Zentalis Pharmaceuticals Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 15

Zentalis Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

Benzinga
·
May 15

BRIEF-Zentalis Pharmaceuticals Q1 Operating Expenses USD 45.623 Million

Reuters
·
May 15

Zentalis Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
May 02